Human Health Holdings Income Statement

Financials in millions HKD. Fiscal year is July - June.

Millions HKD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	644.43	590.82	1,002	1,122	654.71
Revenue Growth (YoY)	9.07%	-41.02%	-10.70%	71.34%	44.29%
Cost of Revenue	348.97	320.97	408.51	462.11	278.02
Gross Profit	295.46	269.85	593.24	659.69	376.69
Selling, General & Admin	197.7	184.47	211.18	166.7	152.37
Amortization of Goodwill & Intangibles	1.49	1.61	1.61	1.61	1.61
Operating Expenses	265.17	251.7	286.16	230.88	230.63
Operating Income	30.29	18.15	307.07	428.81	146.06
Interest Expense	-6.55	-8.22	-8.3	-2.93	-2.93
Interest & Investment Income	12.7	16.61	8.49	0.2	0.29
Earnings From Equity Investments	-0.24	-1.27	-1.54	-1.98	0.99
Other Non Operating Income (Expenses)	1.96	1.88	2.51	0.82	0.14
EBT Excluding Unusual Items	38.16	27.15	308.23	424.92	144.55
Gain (Loss) on Sale of Investments	2.28	16.58	-6.27	25.52	2.63
Asset Writedown	-10.5	-17.16	-63.15	-10	-
Other Unusual Items	-	-	-	4.82	21.63
Pretax Income	29.94	26.56	238.82	445.26	168.82
Income Tax Expense	3.31	2.38	57.98	69.95	24.37
Earnings From Continuing Operations	26.63	24.19	180.84	375.31	144.45
Minority Interest in Earnings	-0.3	-	-	-	-
Net Income	26.34	24.19	180.84	375.31	144.45
Net Income to Common	26.34	24.19	180.84	375.31	144.45
Net Income Growth	8.88%	-86.62%	-51.82%	159.81%	-
Shares Outstanding (Basic)	380	380	380	380	380
Shares Outstanding (Diluted)	380	380	380	380	380
EPS (Basic)	0.07	0.06	0.48	0.99	0.38
EPS (Diluted)	0.07	0.06	0.48	0.99	0.38
EPS Growth	8.27%	-86.61%	-51.86%	159.81%	-
Free Cash Flow	90.83	-26.3	580.24	219.3	71.44
Free Cash Flow Per Share	0.24	-0.07	1.53	0.58	0.19
Dividend Per Share	0.030	0.028	0.160	0.300	0.120
Dividend Growth	7.14%	-82.50%	-46.67%	150.00%	-
Gross Margin	45.85%	45.67%	59.22%	58.81%	57.54%
Operating Margin	4.70%	3.07%	30.65%	38.22%	22.31%
Profit Margin	4.09%	4.09%	18.05%	33.46%	22.06%
Free Cash Flow Margin	14.09%	-4.45%	57.92%	19.55%	10.91%
EBITDA	50.62	39.07	323.46	437.63	155.85
EBITDA Margin	7.85%	6.61%	32.29%	39.01%	23.80%
D&A For EBITDA	20.34	20.92	16.39	8.83	9.79
EBIT	30.29	18.15	307.07	428.81	146.06
EBIT Margin	4.70%	3.07%	30.65%	38.22%	22.31%
Effective Tax Rate	11.05%	8.94%	24.28%	15.71%	14.43%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.